Notifiable Avian Influenza
Hazard Specific Plan

May 2007

Table of Contents

• Abbreviations and Acronyms
• Part 1. About this document
  • 1.1 Introduction
  • 1.2 Objectives
  • 1.3 Audience
  • 1.4 Related Documents
  • 1.5 Amendments and Revisions
  • 1.6 Bibliography
• Part 2. Avian Influenza Overview
  • 2.1 Etiology
    • 2.1.1 Canadian Food Inspection Agency Definition
    • 2.1.2 History
  • 2.2 Susceptible Species
  • 2.3 Global Distribution
  • 2.4 Epidemiology
    • 2.4.1 Incubation Period-Critical Period
    • 2.4.2 Persistence in the Environment
    • 2.4.3 Modes of Introduction and Transmission
  • 2.5 Pathogenesis
  • 2.6 Diagnosis
    • 2.6.1 Clinical Signs
    • 2.6.2 Gross Pathologic Lesions
    • 2.6.3 Morbidity and Mortality
    • 2.6.4 Laboratory Diagnosis
    • 2.6.5 Differential Diagnoses
  • 2.7 Notifiable Avian Influenza Case Definition
    • 2.7.1 Suspect Case
    • 2.7.2 Presumptive Case
    • 2.7.3 Confirmed Case
  • 2.8 Immunity
    • 2.8.1 Active
    • 2.8.2 Passive
    • 2.8.3 Vaccination
  • 2.9 Public Health
  • 2.10 Biocontainment
• Part 3. Authorities and Principles of Control
  • 3.1 Statutory Authority
  • 3.2 Policy Statement
  • 3.3 Principles of Control
  • 3.4 Definition of Commercial and Non-Commercial Poultry Flock
    • 3.4.1 Risk Assessment
    • 3.4.2 Risk Management
  • 3.5 Definition of Disease Control Zones for Notifiable Avian Influenza
    • 3.5.1 Disease Control Zones Before the Declaration of A Control Area
    • 3.5.2 Disease Control Zones After the Declaration of A Control Area
  • 3.6 Control Measures for Non-Avian Species
    • 3.6.1 Control Measures for Pet Animals
    • 3.6.2 Control Measures for Swine Population
• Part 4. Emergency Response
  • 4.1 Initial NAI Investigation
    • 4.1.1 Initial NAI Investigation Procedures when AI is Suspected
      • 4.1.1.1 Initial Investigation
      • 4.1.1.2 Completing the Avian Disease Premises Investigation Questionnaire and Reports
    • 4.1.2 Specimen Collection, Submission, and Testing
      • 4.1.2.1 Packaging and Shipping Requirements for Avian Influenza Specimens
      • 4.1.2.2 Laboratory Testing
      • 4.1.2.3 Confirmatory Testing
      • 4.1.2.4 Laboratory Notification of Results
    • 4.1.3 Premises Control Actions
      • 4.1.3.1 Declaration of Infected Premises
      • 4.1.3.2 Restrictions at the Declared Infected Place
      • 4.1.3.3 Actions in the Vicinity of an Infected Place
    • 4.1.4 Tracing on Positive NAI Infected Places
      • 4.1.4.1 Critical Period
      • 4.1.4.2 Trace-out Investigations
      • 4.1.4.3 Trace-in Investigations
      • 4.1.4.4 Tracings to Special Premises
    • 4.1.5 Surveillance
      • 4.1.5.1 Dead Bird Surveillance
      • 4.1.5.2 Pre-movement Testing
      • 4.1.5.3 Sick Call Testing
      • 4.1.5.4 Hatcheries
      • 4.1.5.5 Depopulation Testing
    • 4.1.6 Eradication Activities at Positive NAI Infected Places
      • 4.1.6.1 Evaluation
      • 4.1.6.2 Slaughter of Susceptible Species
      • 4.1.6.3 Disposal of Carcasses, Products, and By-Products
      • 4.1.6.4 Removal of Non-susceptible Animals and Animal Products from NAI Infected Places
    • 4.1.7 Vector Control
    • 4.1.8 Wildlife Control
    • 4.1.9 Decontamination
      • 4.1.9.1 General Principles of Decontamination
      • 4.1.9.2 Decontamination of Premises
      • 4.1.9.3 Decontamination of Carcasses
      • 4.1.9.4 Equipment Decontamination
    • 4.1.10 Re-stocking and Release of Infected Place Declaration
      • 4.1.10.1 Approved Sources of Poultry
      • 4.1.10.2 Release of Infected Place Declaration With Restocking
      • 4.1.10.3 Release of Infected Place Declaration Without Restocking
    • 4.1.11 Actions in the Vicinity of a Detection of HPNAI in Wild Birds
      • 4.1.11.1 Disease Control Actions in the Vicinity of the HPNAI Detection in Wild Birds
    • 4.1.12 Disease Control Actions in the Vicinity of LPAI Detection in Wild Birds
  • 4.2 NAI Emergency Response: When a Control Area Has Been Designated
    • 4.2.1 Control Area Procedures
      • 4.2.1.1 Control Area Declaration
      • 4.2.1.2 Zones Within the Control Area
      • 4.2.1.3 Communication and Public Notification
      • 4.2.1.4 Surveillance
      • 4.2.1.5 Movement Restrictions Within the Control Area
    • 4.2.2 Vaccination
      • 4.2.2.1 Domestic Considerations and Vaccination Decision Tree
      • 4.2.2.2 Vaccine Distribution
      • 4.2.2.3 Vaccine Administration
      • 4.2.2.4 Movement Restrictions for Vaccinates
      • 4.2.2.5 Monitoring and Surveillance of Vaccinates
      • 4.2.2.6 Cessation of Vaccination
• Part 5. Proof of Freedom Procedures
  • 5.1 Criteria for Proof of Freedom
  • 5.2 Surveillance
  • 5.3 Release of Control Area Restrictions
  • 5.4 Country Freedom Declaration

Appendices

• Appendix A Glossary
• Appendix B Avian Influenza Risk Estimator
• Appendix C Summary of NAI Disease Control Activities - Scenarios
• Appendix D Checklist and Communication Plan - Initial Avian Influenza Investigation
• Appendix E Go Kit and Transport Media for Poultry Specimen Collection
• Appendix F Enhanced Biosecurity Measures
• Appendix G Avian Influenza Clinical Signs
• Appendix H Avian Disease Premises Investigation Questionnaire
• Appendix I Avian Influenza Laboratory Network Laboratory List
• Appendix J Blood Collection and Euthanasia Techniques for Poultry
• Appendix K Procedure for Poultry Specimen Collection and Laboratory Submission to the Avian Influenza Laboratory Network
• Appendix L Avian Influenza Shipping Fact Sheet
• Appendix M Guidelines for the Movement of Poultry and Poultry Products Within the Control Area
• Appendix N Overview of Avian Influenza Vaccines
• Appendix O Notifiable Avian Influenza Vaccination Decision Tree

Next page: Abbreviations and Acronyms